Endoceutics is a private pharmaceutical company operating in the fields of women’s health and hormone-sensitive cancer prevention and treatment.Endoceutics is a private pharmaceutical company operating in the fields of women’s health and hormone-sensitive cancer prevention and treatment.
Endoceutics is actively committed to advancing basic sciences, clinical research and development, world-class manufacturing, and product commercialization worldwide.
Intrarosa (prasterone) was approved by the FDA in November 2016, for the treatment treatment of dyspareunia, a symptom of vulvovaginal atrophy due to menopause.
Endoceutics is now focusing on developing non estrogen-based therapies for sexual dysfunction and the other symptoms of menopause, including hot flashes, osteoporosis, muscle loss, and type 2 diabetes. Innovative hormonal therapies for breast, uterine and prostate cancer, male hypogonadism, and endometriosis are also under development.
Contact
2795 Laurier Blvd, Suite 500, Quebec (Quebec) G1V 4M7
Tel +1.418.653.0033
Website http://www.endoceutics.com/
Email info@endoceutics.com
Dr. Fernand Labrie shares the significant achievements of Endoceutics, in launching its first breakthrough product for post-menopausal vulvar and vaginal atrophy, known as the ‘female Viagra’, the innovations behind the…
Dr. Fernand Labrie, long before becoming CEO of EndoCeutics, discovered and developed medical castration with GnRH agonists, a breakthrough treatment that quickly replaced surgical castration back in the early 1980s.…
See our Cookie Privacy Policy Here
